Critics of this study suggest that a comparison with metformin, previously shown to improve asthma outcomes, would be necessary to further reveal the efficacy of GLP-1 receptor agonist treatment in this setting, as well as some statistical/methodical issues [47]. The gene discussed is GLP1R; the disease is asthma.